4.3 Article

Extent and consequences of misclassified injury diagnoses in a national hospital discharge registry

Journal

INJURY PREVENTION
Volume 17, Issue 2, Pages 108-113

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/ip.2010.028951

Keywords

-

Funding

  1. Uppsala University

Ask authors/readers for more resources

Background Classification of injuries and estimation of injury severity on the basis of ICD-10 injury coding are powerful epidemiological tools. Little is known about the characteristics and consequences of primary coding errors and their consequences for such applications. Materials and methods From the Swedish national hospital discharge register, 15 899 incident injury cases primarily admitted to the two hospitals in Uppsala County between 2000 and 2004 were identified. Of these, 967 randomly selected patient records were reviewed. Errors in injury diagnosis were corrected, and the consequences of these changes were analysed. Results Out of 1370 injury codes, 10% were corrected, but 95% of the injury codes were correct to the third position. In 21% (95% CI 19% to 24%) of 967 hospital admissions, at least one ICD-10 code for injury was changed or added, but only 13% (127) had some change made to their injury mortality diagnosis matrix classification. Among the cases with coding errors, the mean ICD-based injury severity score changed slightly (difference 0.016; 95% CI 0.007 to 0.032). The area under the receiver operating characteristics curve was 0.892 for predicting hospital mortality and remained essentially unchanged after the correction of codes (95% CI for difference -0.022 to 0.013). Conclusion Errors in ICD-10-coded injuries in hospital discharge data were common, but the consequences for injury categorisation were moderate and the consequences for injury severity estimates were in most cases minor. The error rate for detailed levels of cause-of-injury codes was high and may be detrimental for identifying specific targets for prevention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Oncology

Rapid ascertainment of uptake of a new indication for abiraterone by use of three nationwide health care registries in Sweden

Giuseppe Fallara, Ingela Franck Lissbrant, Johan Styrke, Francesco Montorsi, Rolf Gedeborg, Fredrik Sandin, Par Stattin

ACTA ONCOLOGICA (2021)

Article Oncology

Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

Gincy George, Hanna Vikman, Rolf Gedeborg, Ingela Franck Lissbrant, Hans Garmo, Johan Styrke, Mieke Van Hemelrijck, Par Stattin

Summary: Men with castration resistant prostate cancer (CRPC) on GnRH plus androgen receptor targeted (ART) drugs such as abiraterone or enzalutamide have an increased risk of cardiovascular disease (CVD), especially those with a recent history of CVD. It is recommended to closely monitor the cardiovascular health of these patients.

ACTA ONCOLOGICA (2021)

Letter Oncology

Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Rolf Gedeborg, Hans Garmo, Camilla Thellenberg-Karlsson, Giuseppe Fallara, Johan Styrke, Ingela Franck Lissbrant, Par Stattin

ACTA ONCOLOGICA (2022)

Article Medical Informatics

Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males

Mieke Van Hemelrijck, Eugenio Ventimiglia, David Robinson, Rolf Gedeborg, Lars Holmberg, Par Stattin, Hans Garmo

Summary: This study developed a method to predict life expectancy at a population level based on factors such as age, Charlson Comorbidity Index (CCI), and Drug Comorbidity Index (DCI). Simulations were used to estimate life expectancy by considering potential future changes in CCI and DCI. The results showed good agreement between observed and simulated survival curves, with a decrease in life expectancy with increasing age and comorbidity.

BMC MEDICAL INFORMATICS AND DECISION MAKING (2022)

Article Urology & Nephrology

Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

Rolf Gedeborg, Lars Lindhagen, Stacy Loeb, Johan Styrke, Hans Garmo, Par Stattin

Summary: The study found that men with prostate cancer treated with androgen deprivation therapy (ADT) had a higher risk of death from COVID-19, but this association was substantially attenuated after adjustment. The increased mortality from COVID-19 in these patients was mainly related to factors such as older age, comorbidity, and advanced prostate cancer, and there was no evidence to support the hypothesis that ADT is associated with improved COVID-19 outcomes.

SCANDINAVIAN JOURNAL OF UROLOGY (2022)

Article Medicine, General & Internal

The impact and causal directions for the associations between diagnosis of ADHD, socioeconomic status, and intelligence by use of a bi-directional two-sample Mendelian randomization design

Madeleine Michaelsson, Shuai Yuan, Hakan Melhus, John A. Baron, Liisa Byberg, Susanna C. Larsson, Karl Michaelsson

Summary: This study used a bi-directional two-sample Mendelian randomization design to examine the relationships between ADHD, socioeconomic status, and intelligence. The results suggest that ADHD diagnosis could be a direct consequence of socioeconomic factors, independent of intelligence, while ADHD may lead to modestly lower socioeconomic status. Low intelligence does not seem to be a major independent cause or consequence of ADHD.

BMC MEDICINE (2022)

Article Environmental Sciences

Serum levels of perfluoroalkyl substances (PFAS) and body composition - A cross-sectional study in a middle-aged population

P. Monica Lind, Lars Lind, Samira Salihovic, Hakan Ahlstrom, Karl Michaelsson, Joel Kullberg, Robin Strand

Summary: According to this study, some PFAS are inversely related to fat mass, but not all PFAS show this relationship, and it mainly occurs in women.

ENVIRONMENTAL RESEARCH (2022)

Article Oncology

Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy

Rolf Gedeborg, Stacy Loeb, Johan Styrke, Ritva Kiiski-Berggren, Hans Garmo, Par Stattin

Summary: This study analyzed data from the Prostate Cancer data Base Sweden (PCBaSe) and found that men undergoing androgen deprivation therapy (ADT) had increased risks of testing positive for COVID-19 infection and subsequent hospital admission/death. However, after adjusting for age, comorbidity, and prostate cancer risk category, these associations were attenuated. The findings suggest that the increased risks may be attributed to confounding factors such as old age, cancer-associated morbidity, and other comorbidities rather than a direct effect of the therapy.

INTERNATIONAL JOURNAL OF CANCER (2022)

Review Public, Environmental & Occupational Health

Federated analyses of multiple data sources in drug safety studies

Rolf Gedeborg, Wilmar Igl, Bodil Svennblad, Peter Wilen, Benedicte Delcoigne, Karl Michaelsson, Rickard Ljung, Nils Feltelius

Summary: Federated Analyses enable real-time, interactive, centralized statistical processing of individual-level data from different sources without transferring sensitive personal data, potentially improving the precision of studies on rare side effects of new drugs.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023)

Article Health Care Sciences & Services

Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence

Marcus Westerberg, Kerri Beckmann, Rolf Gedeborg, Sandra Irenaeus, Lars Holmberg, Hans Garmo, Par Stattin

Summary: This study investigated the impact of missing data on the M stage in a clinical cancer register on estimates of incidence of metastatic prostate cancer. The results showed a high proportion of missing M stage, with varying incidence estimates depending on the imputation method used. It was concluded that a combination of deterministic imputation and multiple imputation can provide plausible estimates of metastatic prostate cancer incidence.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2023)

Article Medicine, General & Internal

Validation of myocarditis diagnoses in the Swedish patient register for analyses of potential adverse reactions to COVID-19 vaccines

Rolf Gedeborg, Lennart Holm, Nils Feltelius, Anders Sundstrom, Kai M. Eggers, Marja-Leena Nurminen, Maria Grunewald, Nicklas Pihlstrom, Bjorn Zethelius, Rickard Ljung

Summary: Validation of register-based myocarditis diagnoses through manual patient record review showed a confirmation rate of 96%. Reclassification had minimal impact on the incidence rate ratios for myocarditis following COVID-19 vaccination.

UPSALA JOURNAL OF MEDICAL SCIENCES (2023)

Letter Medicine, General & Internal

Association between SARS-CoV-2 vaccination and healthcare contacts for menstrual disturbance and bleeding in women before and after menopause: nationwide, register based cohort study

Rickard Ljung, YiYi Xu, Anders Sundstrom, Susannah Leach, Ebba Hallberg, Maria Bygdell, Maria Larsson, Veronica Arthurson, Magnus Gisslen, Rolf Gedeborg, Fredrik Nyberg

BMJ-BRITISH MEDICAL JOURNAL (2023)

Article Medicine, General & Internal

Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Christian Corsini, Hans Garmo, Andri Wilberg Orrason, Rolf Gedeborg, Par Stattin, Marcus Westerberg

Summary: This study observed a clinically meaningful increase in mean survival in men with de novo mCSPC in Sweden between 2008 and 2020, along with improvements in treatment for advanced prostate cancer.

JAMA NETWORK OPEN (2023)

Meeting Abstract Urology & Nephrology

TIME ON TREATMENT WITH ABIRATERONE IN MEN WITH DE NOVO METASTATIC CASTRATION SENSITIVE PROSTATE CANCER

Par Stattin, Hans Garmo, Camilla Thellenberg-Karlsson, Giuseppe Fallara, Johan Styrke, Ingela Franck Lissbrant, Rolf Gedeborg

JOURNAL OF UROLOGY (2022)

Article Critical Care Medicine

Optimized diagnosis-based comorbidity measures for all-cause mortality prediction in a national population-based ICU population

Anna Aronsson Dannewitz, Bodil Svennblad, Karl Michaelsson, Miklos Lipcsey, Rolf Gedeborg

Summary: This study aimed to optimize the prediction of long-term all-cause mortality of intensive care unit (ICU) patients using quantitative register-based comorbidity information. The results showed that baseline comorbidity measures, including the time interval from the most recent hospital stay, significantly improved the prediction of mortality after ICU admission compared to the Charlson index and the SAPS score.

CRITICAL CARE (2022)

No Data Available